Meet us at J.P.Morgan Healthcare Conference
As we prepare to wrap up another exciting year for Aitia, we’re eagerly looking forward to a bustling 2024. For now, we’re gearing up for the J.P. Morgan conference, where our CEO, Colin Hill and President, COO, Jean-Michel Gries will be in attendance. Be sure to connect with them and request a meeting through the […]
Driving the Discovery and Clinical Development of the Next Generation of Alzheimer’s Disease Drugs: Join us at the CNS Summit 2023
We are thrilled to announce that Aitia will be participating in the CNS Summit 2023 conference. Colin Hill, will be joined by Rudolph Tanzi, Vice-Chair of Neurology, Director of the Genetics and Aging Research Unit, and Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard Medical School, and Ole Isacson, Professor & Chair […]
Prediction of Amyloid PET Positivity from Blood-Based Biomarkers, Proteomics, and Clinical Data Discovered through Aitia’s Digital Twins to be Presented at CTAD 2023
We are delighted to announce that Aitia will be at the Clinical Trials on Alzheimer’s Disease conference (CTAD) being held from October 24-27 in Boston, MA. We will be presenting a poster focused on prediction of Amyloid PET positivity of Alzheimer’s Disease (AD) through Gemini Digital Twins of AD patients, based on blood-based biomarkers and […]
Leveraging AI in Healthcare and Life Sciences Discussion: Join our CEO, Colin Hill at the Sixth Annual International IP Summit
We are delighted to announce that Aitia will be participating in the Sixth Annual International IP Summit. Our CEO, Colin Hill, will be a featured speaker at an engaging discussion titled: Leveraging AI in Healthcare and Life Sciences: Key Legal Considerations. Colin will be joined by industry experts Dr. Bernardo Bizzo, the Senior Director of […]
A Digital Boost for Pharmaceutical R&D: Join our CEO, Colin Hill at the Orion Day in Finland
We are thrilled to announce that Aitia will be participating at the Orion Day conference. Our CEO, Colin Hill, will be giving a keynote titled: AI-Powered Digital Twins: Revolutionizing Pharmaceutical Drug Discovery and Clinical Development to Create the Next Generation of Breakthrough Drugs. During the keynote, Colin will share valuable insights and engage in a dynamic […]
Accelerating Drug Target Identification and Validation with AI and Digital Twins: Join our CBO, Joseph Donahue at BioTechX Europe 2023
We are thrilled to announce that Aitia will be participating in Basel at the BioTechX Europe 2023 conference. Our CBO, Joseph Donahue, will be taking the stage in the AI in Drug Development and Discovery session to talk about Aitia’s commitment in accelerating AI-driven discoveries and share valuable insights on harnessing Causal AI and Digital […]
CEO and Investor Roundtable Discussion: Join our CEO, Colin Hill at BioCentury East-West Pharma Summit 2023
We are delighted to announce that Aitia will be participating in the prestigious global East-West Pharma Summit 2023 conference. Our CEO, Colin Hill, will be a featured speaker at a roundtable discussion along with industry experts Christine Aylward, the Founding & Managing Partner of Magnetic Ventures, Nathalie Beslay, the Co-founder of NAAIA, Michelle Chen, PH.D., […]
Driving Research in Pancreatic Cancer: Join our CEO, Colin Hill on the PanCAN Scientific Summit 2023
We are thrilled to announce that Aitia will be participating in the highly anticipated PanCAN Scientific Summit 2023 conference. Our CEO, Colin Hill, will be taking the stage in the scientific session to talk about Aitia’s commitment in accelerating AI-driven discoveries in pancreatic cancer and share valuable insights on harnessing AI technology and Digital Twins […]
Fireside Chat: Join our CEO, Colin Hill on the Longwood Healthcare Leaders Fall Conference
We are delighted to announce that Aitia will be participating in the industry-leading Longwood Healthcare Leaders Fall Conference. Our CEO, Colin Hill, will moderate a Fireside Chat with industry experts Dave Reese, EVP R&D at Amgen and Priya Singhal, EVP & Head, Development & Interim Head of Research at Biogen. The conference focuses on a […]
Webinar | From the beta-amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease
We are delighted to announce our upcoming webinar on Thursday, September 14, 10:00 am ET. From the beta-amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease. Alzheimer’s disease research has taken center stage in the world of drug discovery and clinical development. The convergence of causal AI, supercomputing power, and multi-omic […]